# Apogee Enterprises, Inc.: financial statements, quarterly

APOG · Nasdaq · CIK 6845 · [Materials](/sectors/materials.md) · fiscal year ends Mar 1

Pages: [Overview](/companies/apog.md) · [Financials](/companies/apog/financials.md) · [Filings](/companies/apog/filings.md) · [Insiders](/companies/apog/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/apog/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2024 (2023-11-25) | Q4 FY2024 (2024-03-02) | Q1 FY2025 (2024-06-01) | Q2 FY2025 (2024-08-31) | Q3 FY2025 (2024-11-30) | Q4 FY2025 (2025-03-01) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-30) | Q3 FY2026 (2025-11-29) | Q4 FY2026 (2026-02-28) | Q1 FY2027 (2026-05-30) | Q2 FY2027 (2026-08-29) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [340](/filings/0000006845-25-000022.md) | [362 d](/filings/0000006845-26-000023.md) | [332](/filings/0000006845-25-000128.md) | [342](/filings/0000006845-25-000152.md) | [341](/filings/0000006845-26-000010.md) | [346 d](/filings/0000006845-26-000023.md) | [347](/filings/0000006845-26-000063.md) | [358](/filings/0000006845-26-000103.md) | [349](/filings/0000006845-26-000010.md) | [351 d](/filings/0000006845-26-000023.md) | [343](/filings/0000006845-26-000063.md) | [391](/filings/0000006845-26-000103.md) |
| Cost of revenue | $m | [249](/filings/0000006845-25-000022.md) | [273 d](/filings/0000006845-26-000023.md) | [233](/filings/0000006845-25-000128.md) | [245](/filings/0000006845-25-000152.md) | [252](/filings/0000006845-26-000010.md) | [271 d](/filings/0000006845-26-000023.md) | [271](/filings/0000006845-26-000063.md) | [276](/filings/0000006845-26-000103.md) | [266](/filings/0000006845-26-000010.md) | [273 d](/filings/0000006845-26-000023.md) | [268](/filings/0000006845-26-000063.md) | [295](/filings/0000006845-26-000103.md) |
| Gross profit | $m | [90.3](/filings/0000006845-25-000022.md) | [88.5 d](/filings/0000006845-26-000023.md) | [98.9](/filings/0000006845-25-000128.md) | [97.3](/filings/0000006845-25-000152.md) | [89.1](/filings/0000006845-26-000010.md) | [74.6 d](/filings/0000006845-26-000023.md) | [75.1](/filings/0000006845-26-000063.md) | [82.6](/filings/0000006845-26-000103.md) | [83.0](/filings/0000006845-26-000010.md) | [78.7 d](/filings/0000006845-26-000023.md) | [75.0](/filings/0000006845-26-000063.md) | [96.2](/filings/0000006845-26-000103.md) |
| Selling, general and administrative | $m | [52.7](/filings/0000006845-25-000022.md) | [66.6 d](/filings/0000006845-26-000023.md) | [57.5](/filings/0000006845-25-000128.md) | [55.4](/filings/0000006845-25-000152.md) | [60.5](/filings/0000006845-26-000010.md) | [68.4 d](/filings/0000006845-26-000023.md) | [68.2](/filings/0000006845-26-000063.md) | [55.7](/filings/0000006845-26-000103.md) | [58.1](/filings/0000006845-26-000010.md) | [53.0 d](/filings/0000006845-26-000023.md) | [56.2](/filings/0000006845-26-000063.md) | [62.7](/filings/0000006845-26-000103.md) |
| Operating income | $m | [37.6](/filings/0000006845-25-000022.md) | [21.9 d](/filings/0000006845-26-000023.md) | [41.4](/filings/0000006845-25-000128.md) | [42.0](/filings/0000006845-25-000152.md) | [28.6](/filings/0000006845-26-000010.md) | [6.1 d](/filings/0000006845-26-000023.md) | [6.9](/filings/0000006845-26-000063.md) | [26.9](/filings/0000006845-26-000103.md) | [24.9](/filings/0000006845-26-000010.md) | [25.8 d](/filings/0000006845-26-000023.md) | [18.8](/filings/0000006845-26-000063.md) | [33.5](/filings/0000006845-26-000103.md) |
| Interest expense | $m | [1.5](/filings/0000006845-25-000022.md) | [0.9 d](/filings/0000006845-26-000023.md) | [0.5](/filings/0000006845-25-000128.md) | [1.1](/filings/0000006845-25-000152.md) | [1.0](/filings/0000006845-26-000010.md) | [3.5 d](/filings/0000006845-26-000023.md) | [3.8](/filings/0000006845-26-000063.md) | [4.1](/filings/0000006845-26-000103.md) | [3.2](/filings/0000006845-26-000010.md) | [2.8 d](/filings/0000006845-26-000023.md) | [2.8](/filings/0000006845-26-000063.md) | [3.6](/filings/0000006845-26-000103.md) |
| Income tax | $m | [8.3](/filings/0000006845-25-000022.md) | [3.5 d](/filings/0000006845-26-000023.md) | [10.1](/filings/0000006845-25-000128.md) | [10.5](/filings/0000006845-25-000152.md) | [6.7](/filings/0000006845-26-000010.md) | [0.3 d](/filings/0000006845-26-000023.md) | [5.1](/filings/0000006845-26-000063.md) | [4.3](/filings/0000006845-26-000103.md) | [7.6](/filings/0000006845-26-000010.md) | [6.4 d](/filings/0000006845-26-000023.md) | [4.4](/filings/0000006845-26-000063.md) | [8.0](/filings/0000006845-26-000103.md) |
| Net income | $m | [27.0](/filings/0000006845-25-000022.md) | [15.7 d](/filings/0000006845-26-000023.md) | [31.0](/filings/0000006845-26-000010.md) | [30.6](/filings/0000006845-26-000010.md) | [21.0](/filings/0000006845-26-000010.md) | [2.5 d](/filings/0000006845-26-000023.md) | [(2.7)](/filings/0000006845-26-000103.md) | [23.6](/filings/0000006845-26-000103.md) | [16.5](/filings/0000006845-26-000010.md) | [16.6 d](/filings/0000006845-26-000023.md) | [11.5](/filings/0000006845-26-000103.md) | [22.4](/filings/0000006845-26-000103.md) |
| Diluted EPS | $ per share | [1.23](/filings/0000006845-25-000022.md) | not reported | [1.41](/filings/0000006845-25-000128.md) | [1.40](/filings/0000006845-25-000152.md) | [0.96](/filings/0000006845-26-000010.md) | not reported | [(0.13)](/filings/0000006845-26-000063.md) | [1.10](/filings/0000006845-26-000103.md) | [0.77](/filings/0000006845-26-000010.md) | not reported | [0.54](/filings/0000006845-26-000063.md) | [1.07](/filings/0000006845-26-000103.md) |
| Basic EPS | $ per share | [1.24](/filings/0000006845-25-000022.md) | not reported | [1.42](/filings/0000006845-25-000128.md) | [1.40](/filings/0000006845-25-000152.md) | [0.96](/filings/0000006845-26-000010.md) | not reported | [(0.13)](/filings/0000006845-26-000063.md) | [1.10](/filings/0000006845-26-000103.md) | [0.78](/filings/0000006845-26-000010.md) | not reported | [0.55](/filings/0000006845-26-000063.md) | [1.08](/filings/0000006845-26-000103.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2024 (2023-11-25) | FY2024 (2024-03-02) | Q1 FY2025 (2024-06-01) | Q2 FY2025 (2024-08-31) | Q3 FY2025 (2024-11-30) | FY2025 (2025-03-01) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-30) | Q3 FY2026 (2025-11-29) | FY2026 (2026-02-28) | Q1 FY2027 (2026-05-30) | Q2 FY2027 (2026-08-29) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [23.4](/filings/0000006845-24-000004.md) | [37.2](/filings/0000006845-25-000049.md) | [30.4](/filings/0000006845-24-000222.md) | [51.0](/filings/0000006845-24-000254.md) | [43.9](/filings/0000006845-25-000022.md) | [41.4](/filings/0000006845-26-000023.md) | [32.8](/filings/0000006845-25-000128.md) | [39.5](/filings/0000006845-25-000152.md) | [41.3](/filings/0000006845-26-000010.md) | [39.5](/filings/0000006845-26-000103.md) | [26.4](/filings/0000006845-26-000063.md) | [36.5](/filings/0000006845-26-000103.md) |
| Current assets | $m | [372](/filings/0000006845-24-000004.md) | [359](/filings/0000006845-25-000049.md) | [373](/filings/0000006845-24-000222.md) | [394](/filings/0000006845-24-000254.md) | [431](/filings/0000006845-25-000022.md) | [442](/filings/0000006845-26-000023.md) | [448](/filings/0000006845-25-000128.md) | [460](/filings/0000006845-25-000152.md) | [436](/filings/0000006845-26-000010.md) | [439](/filings/0000006845-26-000103.md) | [430](/filings/0000006845-26-000063.md) | [472](/filings/0000006845-26-000103.md) |
| Total assets | $m | [895](/filings/0000006845-24-000004.md) | [884](/filings/0000006845-26-000023.md) | [889](/filings/0000006845-24-000222.md) | [917](/filings/0000006845-24-000254.md) | [1,181](/filings/0000006845-25-000022.md) | [1,175](/filings/0000006845-26-000023.md) | [1,157](/filings/0000006845-25-000128.md) | [1,155](/filings/0000006845-25-000152.md) | [1,116](/filings/0000006845-26-000010.md) | [1,122](/filings/0000006845-26-000103.md) | [1,101](/filings/0000006845-26-000063.md) | [1,244](/filings/0000006845-26-000103.md) |
| Current liabilities | $m | [237](/filings/0000006845-24-000004.md) | [245](/filings/0000006845-25-000049.md) | [227](/filings/0000006845-24-000222.md) | [239](/filings/0000006845-24-000254.md) | [264](/filings/0000006845-25-000022.md) | [285](/filings/0000006845-26-000023.md) | [253](/filings/0000006845-25-000128.md) | [262](/filings/0000006845-25-000152.md) | [230](/filings/0000006845-26-000010.md) | [267](/filings/0000006845-26-000103.md) | [245](/filings/0000006845-26-000063.md) | [265](/filings/0000006845-26-000103.md) |
| Long-term debt | $m | [101](/filings/0000006845-24-000004.md) | [62.0](/filings/0000006845-25-000049.md) | [77.0](/filings/0000006845-24-000222.md) | [62.0](/filings/0000006845-24-000254.md) | [272](/filings/0000006845-25-000022.md) | [285](/filings/0000006845-26-000023.md) | [311](/filings/0000006845-25-000128.md) | [270](/filings/0000006845-25-000152.md) | [255](/filings/0000006845-26-000010.md) | [232](/filings/0000006845-26-000103.md) | [237](/filings/0000006845-26-000063.md) | [336](/filings/0000006845-26-000103.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [456](/filings/0000006845-25-000022.md) | [471](/filings/0000006845-26-000023.md) | [480](/filings/0000006845-26-000010.md) | [506](/filings/0000006845-26-000010.md) | [522](/filings/0000006845-26-000010.md) | [488](/filings/0000006845-26-000103.md) | [482](/filings/0000006845-26-000103.md) | [500](/filings/0000006845-26-000103.md) | [512](/filings/0000006845-26-000010.md) | [512](/filings/0000006845-26-000103.md) | [512](/filings/0000006845-26-000103.md) | [523](/filings/0000006845-26-000103.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2024 (2023-11-25) | Q4 FY2024 (2024-03-02) | Q1 FY2025 (2024-06-01) | Q2 FY2025 (2024-08-31) | Q3 FY2025 (2024-11-30) | Q4 FY2025 (2025-03-01) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-30) | Q3 FY2026 (2025-11-29) | Q4 FY2026 (2026-02-28) | Q1 FY2027 (2026-05-30) | Q2 FY2027 (2026-08-29) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [66.7 d](/filings/0000006845-25-000022.md) | [74.9 d](/filings/0000006845-26-000023.md) | [5.5](/filings/0000006845-25-000128.md) | [58.7 d](/filings/0000006845-25-000152.md) | [31.0 d](/filings/0000006845-26-000010.md) | [30.0 d](/filings/0000006845-26-000023.md) | [(19.8)](/filings/0000006845-26-000063.md) | [57.1 d](/filings/0000006845-26-000103.md) | [29.3 d](/filings/0000006845-26-000010.md) | [55.8 d](/filings/0000006845-26-000023.md) | [7.4](/filings/0000006845-26-000063.md) | [35.8 d](/filings/0000006845-26-000103.md) |
| Capital expenditure | $m | [11.9 d](/filings/0000006845-25-000022.md) | [16.2 d](/filings/0000006845-26-000023.md) | [7.2](/filings/0000006845-25-000128.md) | [8.4 d](/filings/0000006845-25-000152.md) | [9.0 d](/filings/0000006845-26-000010.md) | [10.9 d](/filings/0000006845-26-000023.md) | [7.2](/filings/0000006845-26-000063.md) | [4.7 d](/filings/0000006845-26-000103.md) | [6.5 d](/filings/0000006845-26-000010.md) | [9.0 d](/filings/0000006845-26-000023.md) | [6.3](/filings/0000006845-26-000063.md) | [11.5 d](/filings/0000006845-26-000103.md) |
| Dividends paid | $m | [5.2 d](/filings/0000006845-25-000022.md) | [5.4 d](/filings/0000006845-26-000023.md) | [0.0](/filings/0000006845-25-000128.md) | [10.8 d](/filings/0000006845-25-000152.md) | [5.4 d](/filings/0000006845-26-000010.md) | [5.5 d](/filings/0000006845-26-000023.md) | [5.5](/filings/0000006845-26-000063.md) | [5.5 d](/filings/0000006845-26-000103.md) | [5.5 d](/filings/0000006845-26-000010.md) | [5.6 d](/filings/0000006845-26-000023.md) | [5.6](/filings/0000006845-26-000063.md) | [5.5 d](/filings/0000006845-26-000103.md) |
| Share repurchases | $m | [0.0 d](/filings/0000006845-25-000022.md) | [0.0 d](/filings/0000006845-26-000023.md) | [15.1](/filings/0000006845-25-000128.md) | [0.0 d](/filings/0000006845-25-000152.md) | [0.0 d](/filings/0000006845-26-000010.md) | [30.3 d](/filings/0000006845-26-000023.md) | [0.0](/filings/0000006845-26-000063.md) | [0.0 d](/filings/0000006845-26-000103.md) | [0.0 d](/filings/0000006845-26-000010.md) | [15.0 d](/filings/0000006845-26-000023.md) | [9.7](/filings/0000006845-26-000063.md) | [6.4 d](/filings/0000006845-26-000103.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2023 (2022-11-26) | Q1 FY2024 (2023-05-27) | Q2 FY2024 (2023-08-26) | Q3 FY2024 (2023-11-25) | Q1 FY2025 (2024-06-01) | Q2 FY2025 (2024-08-31) | Q3 FY2025 (2024-11-30) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-30) | Q3 FY2026 (2025-11-29) | Q1 FY2027 (2026-05-30) | Q2 FY2027 (2026-08-29) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [22.3](/filings/0000006845-24-000004.md) | [22.4](/filings/0000006845-24-000222.md) | [22.0](/filings/0000006845-24-000254.md) | [22.0](/filings/0000006845-25-000022.md) | [22.1](/filings/0000006845-25-000128.md) | [21.9](/filings/0000006845-25-000152.md) | [21.9](/filings/0000006845-26-000010.md) | [21.3](/filings/0000006845-26-000063.md) | [21.6](/filings/0000006845-26-000103.md) | [21.6](/filings/0000006845-26-000010.md) | [21.3](/filings/0000006845-26-000063.md) | [20.9](/filings/0000006845-26-000103.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 20,895,599 at 2026-10-02, from the cover of the [10-Q filed 2026-10-06](/filings/0000006845-26-000103.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.